A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses
Status:
Completed
Trial end date:
2014-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study it so compare the safety and efficacy profiles of a generic
imiquimod 2.5% cream to the reference listed Zyclara® (imiquimod) cream in the treatment of
actinic keratosis (AK).